Home

QuidelOrtho Corporation - Common Stock (QDEL)

32.56
-2.07 (-5.98%)
NASDAQ · Last Trade: Apr 3rd, 4:13 PM EDT
QuoteNewsPress ReleasesChartHistoricalFAQAboutCompetitors

Competitors to QuidelOrtho Corporation - Common Stock (QDEL)

Abbott Laboratories ABT -0.21%

Abbott Laboratories competes with QuidelOrtho Corporation primarily in the field of diagnostics, particularly through its extensive portfolio of rapid tests and molecular diagnostics. Abbott's broad portfolio includes point-of-care testing and various laboratory diagnostics, which positions it well to address diverse market needs. The strong brand recognition, extensive research capabilities, and global distribution network of Abbott give it a significant competitive advantage over QuidelOrtho.

BD (Becton, Dickinson and Company) BDX -2.01%

BD competes with QuidelOrtho in the medical devices and diagnostics sectors, particularly with its comprehensive range of diagnostic systems and laboratory products. BD's strong global presence and established reputation in the medical community enhance its competitiveness. While QuidelOrtho focuses on specific rapid tests, BD's vast array of diagnostic solutions, including blood collection and culture systems, gives them leverage in broader market segments, giving BD a competitive edge.

Roche Diagnostics

Roche Diagnostics is a significant competitor for QuidelOrtho, particularly in the field of in-vitro diagnostics, where both companies offer rapid tests and laboratory products. Roche's commitment to innovation and its extensive patient testing platforms allow it to capture a large market share. While QuidelOrtho provides specialized rapid diagnostic solutions, Roche's larger scale and more diverse product line create a competitive advantage in addressing broader healthcare needs.

Siemens Healthineers

Siemens Healthineers competes with QuidelOrtho by offering a wide array of medical technologies and innovative diagnostic solutions. Their advanced diagnostic imaging and lab diagnostics divisions allow for comprehensive patient care, setting them apart in the market. Siemens' strong innovation pipeline and established customer relationships create a competitive advantage, providing them an edge over more niche players like QuidelOrtho, which primarily focuses on rapid diagnostics.

Thermo Fisher Scientific Inc. TMO -3.91%

Thermo Fisher Scientific competes with QuidelOrtho by offering a wide range of diagnostic products and services, including advanced laboratory instruments and reagents. The company is known for its strong focus on innovation and extensive investment in R&D, allowing it to maintain a competitive edge in the highly-regulated laboratory space. While QuidelOrtho specializes in certain rapid diagnostic tests, Thermo Fisher's broader product line and technological expertise provide a notable advantage in the diagnostics market.